CD8A and HIV-1 infection: Our recent in vivo deuterium labeling study among treatment-naive HIV-1 infected individuals revealed that during chronic HIV-1 infection, naive T-cell production and loss rates are at least 3-fold increased, yielding life-expectancies of 1.7 and 0.7 years for CD4+ and CD8+ naive T cells, respectively [17].